Stepinska, J.

patient infarction treatment e ffect treatment intervention epti fibatide america region europe atrial fi brillation di fferences study event outcome death fibatide percutaneou trial finition pursuit latin america heart fference investigator events committee signi elevation fi ve times patient outcome creatine 30 days treatment bene fit analysis stroke mortality committee atrial bene fit eur heart j treatment e ffects end-point baseline syndrome brillation variable limit latin result ficant ratio variation table baseline characteristics therapy period st-segment factor kinase event rate adjudication process /iiia multivariable glycoprotein threshold odds ratios e ffect 6 months study drug fidence intervals angina multivariable analysis treatment strategies kinase-mb characteristic reduction management placebo month day 3 infusion